Technologies like Swaasa require support from various stakeholders to generate more evidence. Especially by doing multi-site validations and at community level, because this is where the tool is most useful. But as you all know, these validations required a good amount of funding and here is where the support from IHF and ACT is becoming very important. They are funding a multisite validation study of Swaasa. Once done, this will make Swaasa not only more robust, but government & other public health service providers will come forward for a wider deployment to improve TB case detection at the periphery.
Menu
